Mylan Laboratories Limited (Sterile Products Division) Recalls

FDA
1
Total Recalls
1
Agencies
Oct 2019
First Recall
Oct 2019
Latest Recall

Showing 1-1 of 1 recalls

FDA

Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.

Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.